Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

OD2A-S Overdose Prevention and Response Expansion

Active
2026-RFA-204State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The OD2A-S Overdose Prevention and Response Expansion solicitation, identified as 2026-RFA-204, is issued by the Mississippi Pharmacy agency with a response deadline of August 21, 2026. This initiative is based on the CDC's Overdose Data to Action in States (OD2A-S) framework, which provides funding to state health departments to enhance surveillance and prevention efforts regarding opioids, stimulants, and polysubstance use. The program emphasizes a data-driven approach to combat the overdose crisis, focusing on health equity and the integration of morbidity and mortality surveillance to inform public health responses. Key operational requirements include the implementation of the State Unintentional Drug Overdose Reporting System (SUDORS) and the use of the DOSE system for reporting nonfatal overdoses. The contract outlines rigorous data sharing, quality control, and dissemination mandates, including specific metadata and indicators for data linkage strategies. Funding is allocated based on drug overdose death rates and counts, supporting activities such as comprehensive toxicological testing, Targeted Evaluation Projects to assess care navigation, and the staffing of abstractors for case reporting. Recipients must adhere to strict CDC reporting timelines and utilize culturally responsive frameworks to evaluate and improve harm reduction and care linkage services.

General Info

Mississippi Pharmacy agency solicitation 2026-RFA-204 for overdose prevention and surveillance by August 21, 2026.

Agency

Mississippi → PharmacyView Agency

NAICS

923120 - Administration of Public Health ProgramsView NAICS

Place of Performance

MS, USA

Set-Aside

NONE

Documents

(13)

CDC-RFA-CE-23-0002 Overdose Data to Action in States NOFO

PDF112 pagespresolicitation

References Document for OD2A-S Project

PDF1 pagereferences

Appendix 7: Required Metadata and Indicators for Data Linkage Strategy 5 - OD2A-S CDC-RFA-CE23-2302

PDF3 pagessow

Appendix 9 Surveillance and Prevention Anticipated Funding Amounts

PDF2 pagesother

Appendix 10 Figures OD2A-S 10.30.25

PDF2 pagesother

Appendix 5: SUDORS Anticipated Funding Amounts

PDF2 pagesother

RFA OD2A-S Overdose Prevention and Response Expansion

PDFrfa

Appendix 02 Data Surveillance Checklist OD2A-S Revised 10.30.25

PDF9 pageschecklist

Appendix 1 Data Sharing Requirements for OD2A-S CDC-RFA-CE23-2302

PDF3 pagessow

Appendix 6 CDC-RFA-CE23-2302 SUDORS Abstractor Staffing Guidance

PDF3 pagesguidance

Appendix 8 Targeted Evaluation Project Guidance OD2A-S

PDF3 pagessow

Appendix 04 Comprehensive Toxicology Guidance for OD2A-S CDC-RFA-CE23-2302

PDF5 pagesguidance-document

Appendix 3: OD2A-S CDC Reporting Timelines for Morbidity and Mortality Surveillance

PDF4 pagesreporting-timeline

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyMississippi → Pharmacy
Contacts2 people available
OfficeJackson, MS, 39216, USA
Organization / Agency
Mississippi → Pharmacy
View Agency Profile
Office AddressJackson, MS, 39216, USA
Contacts
Barbara HearnAdministrative Support
Qualandia HookerGrant Analyst

Interested Companies (9)

Show more
Onyxcare Health
JACKSON, MS
Visionaires
Jackson, MS

See All 9 Interested Companies

Start a free trial to view all interested companies, their contact details, and full contractor profiles.

Start Free Trial

Full Description

Show more
The attached documents are provided for informational purposes only and do not require completion. The materials provide background information relevant to the project.

Similar Contracts

Same NAICS industry code

NAICS: 923120
New
Grant
Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India
Solicitation # CDC-RFA-JG-26-0142
Solicitation CDC-RFA-JG-26-0142, titled Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India, is a federal opportunity issued by the Centers for Disease Control and Prevention. The program aims to support India's National AIDS Control Organization, Central Tuberculosis Division, and the Ministry of Health and Family Welfare to enhance systems for epidemic control in alignment with the National AIDS Control Program-VI and the National TB Elimination Program. With an approximate total fiscal year funding of 6,000,000 dollars for Year 1, the initiative focuses on transitioning essential services to local ownership and implementing evidence-based strategies to prevent new infections, facilitate early case detection, and ensure treatment adherence and viral suppression. Key activities under this solicitation include closing gaps in testing and treatment, delivering integrated services for HIV and co-morbidities, and strengthening national program cooperation. By advancing innovative service delivery under local leadership, the project seeks to create a sustainable framework for epidemic control that aligns with U.S. global health priorities to bolster global health security. Interested parties must submit their responses by the deadline of September 16, 2026.
Centers For Disease Control-Ghc

POSTED

about 23 hours ago

DEADLINE

in 29 days
View Details
NAICS: 923120
New
SLED
Enhancement and Expansion of ED-MOUD and Overdose Education and Naloxone Distribution Programs with Outcomes Analysis
Solicitation # 2026-RFA-203
The Mississippi State Department of Health, under the CDC Overdose Data to Action in States Cooperative Agreement, is seeking a subgrantee to enhance and expand Emergency Department-based Medication for Opioid Use Disorder and Overdose Education and Naloxone Distribution programs. This initiative aims to reduce opioid-related morbidity and mortality by improving clinical workflows, expanding access to evidence-based treatment initiation, and strengthening referral pathways and warm-handoff processes to specialty psychiatry and behavioral health services. The project emphasizes the integration of overdose prevention and patient navigation to ensure continuity of care following emergency department encounters. A critical component of the contract is an outcomes-focused analysis to evaluate program effectiveness, patient engagement, and naloxone utilization. This data-driven approach will identify implementation challenges and strategies for sustainability and expansion. The project requires strict adherence to CDC reporting timelines for morbidity and mortality surveillance, including the submission of data via the DOSE and SUDORS systems through May 2028. This solicitation, numbered 2026-RFA-203, was posted on August 14, 2026, with a response deadline of August 28, 2026, and will be performed within the state of Mississippi.
Pharmacy

POSTED

3 days ago

DEADLINE

in 11 days
View Details
NAICS: 923120
New
Grant
Advancing Global Health
Solicitation # DFOP0017890
The Department of State, through the Bureau of Global Health Security and Diplomacy, has issued Annual Program Statement DFOP0017890 to advance the America First Global Health Strategy. This supplemental framework seeks projects that save lives, strengthen health systems, and enhance efficiency to ensure U.S. investments benefit American safety and prosperity. The program focuses on several key areas, including child protection and development for ages 0 to 17, global health security through rapid outbreak detection and containment, and the advancement of integrated health systems, specifically within the Philippines. Total estimated funding is up to 4.5 billion dollars, with the potential for up to 100 awards ranging from a minimum of 500,000 dollars to a maximum of 250 million dollars. Applicants must submit a Statement of Interest (SOI) via grants.gov or MyGrants, adhering to a strict five-page narrative limit and specific formatting requirements. Evaluation is based on a multi-step process including technical eligibility and risk reviews, with equal weighting placed on the quality of the program idea and the organization's capacity and previous grant record. Proposed projects must be completed within one to five years. Key compliance requirements include maintaining an active SAM.gov registration and UEI for phase two proposals, adhering to 2 CFR 200 cost principles, and providing certifications regarding anti-discrimination laws and trafficking in persons for awards exceeding 500,000 dollars performed outside the United States.
Bureau Of Global Health Security And Diplomacy

POSTED

4 days ago

DEADLINE

in 6 months
View Details

More opportunities from Mississippi → Pharmacy

Same awarding agency